Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00917189
Other study ID # R33MH085901
Secondary ID R33MH085901DDTR
Status Completed
Phase N/A
First received June 8, 2009
Last updated October 20, 2016
Start date September 2009
Est. completion date April 2015

Study information

Verified date October 2016
Source State University of New York - Upstate Medical University
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study will test a computer-based treatment for youth with the genetic disorder velocardiofacial syndrome (VCFS) to help them improve skills in memory, attention, and executive functioning.


Description:

Velocardiofacial syndrome (VCFS) is a genetic condition caused by deletion of a segment of the 22nd chromosome at the location 22q11.2. VCFS is characterized by a combination of medical problems related to the palate (velo) and the heart (cardio) and by a distinct facial appearance. Also common in people with VCFS, among other problems, are learning and speech difficulties. These difficulties are specifically categorized as deficits in attention, working memory, and executive functioning. This study will develop and test a computer-based intervention for adolescents with VCFS that will teach them cognitive skills to lessen these deficits.

This study will have three phases. In the first phase, the intervention will be pilot tested with an in-person coach. In the second phase, the intervention will be pilot tested remotely with a video-conferencing coach. In the third phase, the intervention will be delivered remotely, and testing will be expanded to include more participants and a longer assessment period. Information on participant drop-out and level of difficulty will be gathered and used to refine the treatment between phases.

Participation in Phase 1 will last 6 months. At study entry, participants will complete baseline measures that involve a structured diagnostic interview to assess behavioral or emotional difficulties and cognitive testing to assess intellectual functioning. Then they will meet with a study training coach three times a week at their homes. During these sessions, participants will complete exercises in the Challenging our Minds program, a computer-based system designed to improve learning. Exercises will develop skills in seven domains: attention, decision making, memory, understanding relationships between objects, problem solving, communication, and social perception.

Participation in Phase 2 will last 6 to 9 months. Participants in this phase will complete the same baseline measures that occurred at study entry and then complete exercises in Challenging our Minds three times a week. Instead of having a training coach come to their homes, participants in Phase 2 will work with a training coach via video-conferencing software.

Participation in Phase 3 will last 2 years. Participants will undergo assessments at four points: at baseline, after 9 months, after 18 months, and after 27 months. These assessments will include the baseline measures from the previous phases as well as a virtual reality computer task. Between their visits at 9 and 18 months, participants will work with a training coach via video conferencing three times a week to complete the Challenging our Minds exercises.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 16 Years
Eligibility Inclusion Criteria:

- Diagnosis of velocardiofacial syndrome (VCFS)

- IQ score between 70 and 90

Exclusion Criteria:

- Presence of psychotic symptoms

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Challenging Our Minds Program
A computerized cognitive intervention that provides training in attention, memory, and executive function

Locations

Country Name City State
United States SUNY Upstate Medical University Syracuse New York

Sponsors (2)

Lead Sponsor Collaborator
State University of New York - Upstate Medical University National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Mariano MA, Tang K, Kurtz M, Kates WR. Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention. Schiz — View Citation

Mariano MA, Tang K, Kurtz M, Kates WR. Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome. Early Interv Psychiatry. 2016 Sep 15. doi: 10.1111/eip.12367. [Epub a — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The California Learning Test and the Visual Span Test Measured immediately following the intervention at each phase No
Secondary Performance on the Apartment Test Measured immediately following the intervention at each phase No
See also
  Status Clinical Trial Phase
Recruiting NCT00768820 - The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome Phase 4
Completed NCT00105274 - Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study N/A